BioBridges, LLC

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

BioBridges, LLC - overview

Established

2005

Location

Waltham, MA, US

Primary Industry

Pharmaceuticals

About

Based in Massachusetts, US, and founded in 2005 by Dr. Ganesh Kumraj, BioBridges, LLC is a provider of clinical development services within the life sciences industry. Soliant Health, Inc. , a portfolio company of Olympus Partners, acquired BioBridges from Adecco Group.


As of 2024, the company is led by its CEO, Jeff Souza. The company offers a career portfolio management model that includes functional experts and expert content to help clients find medical consultants that meet the objectives of their clinical programs. The company offers pharmaceutical, biotechnology, life sciences, and medical device companies consulting services in areas including biostatistics, clinical operations, data management, clinical operations, and oversight; scientific and medical writing services; non-clinical program management; medical quality assurance consulting; and pharmacovigilance consulting.


Current Investors

Soliant Health, Inc.

Primary Industry

Pharmaceuticals

Sub Industries

Consulting Services, Pharmaceutical Research & Development

Website

www.biobridges.com/

Company Stage

Add-on

Total Amount Raised

Subscriber access only

BioBridges, LLC - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-on, Trade SaleCompletedBioBridges, LLC-
Add-onCompletedBioBridges, LLC-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.